Global Health Ltd
Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]
- Market Cap ₹ 37,455 Cr.
- Current Price ₹ 1,395
- High / Low ₹ 1,514 / 548
- Stock P/E 82.9
- Book Value ₹ 98.9
- Dividend Yield 0.00 %
- ROCE 17.1 %
- ROE 16.2 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 58.3% CAGR over last 5 years
Cons
- Stock is trading at 14.1 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.3% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|
1,382 | 1,343 | 1,456 | 1,500 | 1,447 | 2,167 | 2,694 | 3,153 | |
1,081 | 1,218 | 1,283 | 1,309 | 1,250 | 1,709 | 2,073 | 2,387 | |
Operating Profit | 301 | 125 | 172 | 192 | 197 | 458 | 621 | 766 |
OPM % | 22% | 9% | 12% | 13% | 14% | 21% | 23% | 24% |
45 | 49 | 50 | 44 | 31 | 39 | 64 | 93 | |
Interest | 14 | 28 | 38 | 57 | 73 | 86 | 86 | 76 |
Depreciation | 70 | 86 | 102 | 115 | 123 | 130 | 150 | 165 |
Profit before tax | 262 | 60 | 83 | 64 | 32 | 281 | 449 | 617 |
Tax % | 35% | 45% | 38% | 43% | 11% | 30% | 27% | |
170 | 33 | 51 | 36 | 29 | 196 | 326 | 452 | |
EPS in Rs | 35.10 | 6.78 | 10.44 | 7.36 | 5.81 | 7.75 | 12.16 | 16.84 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 22% |
TTM: | 26% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 58% |
3 Years: | 108% |
TTM: | 86% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 147% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 9% |
3 Years: | 11% |
Last Year: | 16% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 48 | 48 | 49 | 49 | 50 | 51 | 54 | 54 |
Reserves | 976 | 1,136 | 1,246 | 1,300 | 1,333 | 1,565 | 2,375 | 2,600 |
Preference Capital | 32 | 32 | 0 | 0 | 0 | 0 | 0 | |
133 | 423 | 787 | 929 | 931 | 1,109 | 1,122 | 795 | |
328 | 376 | 347 | 388 | 380 | 421 | 547 | 631 | |
Total Liabilities | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,079 |
914 | 1,094 | 1,194 | 1,703 | 1,616 | 1,776 | 2,050 | 2,159 | |
CWIP | 12 | 317 | 666 | 382 | 464 | 439 | 327 | 351 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
559 | 573 | 570 | 581 | 615 | 930 | 1,720 | 1,570 | |
Total Assets | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,079 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
228 | 63 | 166 | 175 | 242 | 311 | 645 | |
-241 | -69 | -249 | -87 | -239 | -421 | -342 | |
-7 | 9 | 97 | -1 | -81 | 160 | 346 | |
Net Cash Flow | -20 | 3 | 14 | 87 | -78 | 50 | 648 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
Debtor Days | 20 | 41 | 41 | 36 | 34 | 30 | 26 |
Inventory Days | 28 | 26 | 26 | 43 | 42 | 36 | 35 |
Days Payable | 92 | 124 | 142 | 147 | 138 | 90 | 114 |
Cash Conversion Cycle | -45 | -56 | -75 | -67 | -62 | -24 | -52 |
Working Capital Days | -23 | -15 | -11 | -22 | -22 | -2 | -18 |
ROCE % | 6% | 6% | 5% | 15% | 17% |
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
1d - Secretarial Compliance Report for the Financial Year 2023-24.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2d - An Earnings Conference Call is scheduled on Monday, May 20, 2024 at 2:00 P.M. (IST) to be hosted by JM Financial, for the fourth quarter …
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
10 May - Monitoring Agency Report for Quarter ended March 31, 2024
- Board Meeting Intimation for Consider And Approve The Standalone And Consolidated Audited Financial Results Of The Company For The Fourth Quarter And Financial Year Ended March 31, 2024. 7 May
- Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2024. 15 Apr
Annual reports
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Dec 2022TranscriptNotesPPT
** Hospital Count**[1] Global Health has 5 hospitals in operation (Gurugram, Indore, Ranchi, Lucknow, and Patna), and 1 hospital under construction (Noida) under the ‘’Medanta’’ Brand.
Company provides healthcare services in 30+ medical specialties and engages 1,300+ doctors, spanning an area of 4.7 msf.
Operational hospitals have 2,467 installed beds.
They also operate 6 multi-specialty clinics at DLF Cybercity Gurugram, Delhi Airport, south Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]